Adma Biologics (ADMA) Other Gross PP&E Adjustments (2016 - 2025)
Adma Biologics (ADMA) has disclosed Other Gross PP&E Adjustments for 13 consecutive years, with $81.9 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments rose 20.4% year-over-year to $81.9 million, compared with a TTM value of $81.9 million through Dec 2025, up 20.4%, and an annual FY2025 reading of $81.9 million, up 20.4% over the prior year.
- Other Gross PP&E Adjustments was $81.9 million for Q4 2025 at Adma Biologics, up from -$19.9 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $81.9 million in Q4 2025 and bottomed at -$19.9 million in Q3 2025.
- Average Other Gross PP&E Adjustments over 5 years is $61.0 million, with a median of $64.2 million recorded in 2022.
- The sharpest move saw Other Gross PP&E Adjustments increased 25.85% in 2022, then tumbled 125.83% in 2025.
- Year by year, Other Gross PP&E Adjustments stood at $52.2 million in 2021, then rose by 22.76% to $64.1 million in 2022, then increased by 7.89% to $69.1 million in 2023, then fell by 1.56% to $68.1 million in 2024, then rose by 20.4% to $81.9 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for ADMA at $81.9 million in Q4 2025, -$19.9 million in Q3 2025, and $74.7 million in Q2 2025.